Je was op zoek naar: afroamerikanci (Kroatisch - Engels)

afroamerikanci
african american

crna/afroamerikanci
black/african american

crnci/afroamerikanci
black/african american

rasa: crnci/ afroamerikanci
race: black/ african

afroamerikanci/afričko podrijetlo/ostalo
african-american/african heritage/other

mnogi afroamerikanci vjerojatno misle da su pobjedili na suđenju .
many african-americans probably think that they won by the trial .

mnogi afroamerikanci , koji nikada ne rade dobili su najmanju svotu novca , dovoljnu da prežive .
many african-americans who never work got minimum amount of money to survive .

167 uključenih bolesnika imalo je medijan dobi 57 godina (raspon 27 do 70 godina; s 5% iznad 65 godina); 64% su bili muškarci; 81% su bili bijele rase, 19% crne rase ili afroamerikanci, i 21% hispanci; 37% imalo je bmi ≥ 30 kg/m2; medijan početne razine hcv rna bio je 6,7 log10 iu/ml; 75% nije imalo cirozu (metavir skor za fibrozu f0-3) i 25% je imalo cirozu (metavir skor za fibrozu f4); 78% imalo je hcv genotipe 1a od kojih je 45% nosilo q80k na početku, i 22% je imalo hcv genotip 1b; 86% imalo je ne-cc il28b alele (ct ili tt); 76% su bili bolesnici bez prethodnog odgovora na peginterferon alfa i ribavirin, te 24% bolesnika nije bilo prethodno liječeno.
the 167 enrolled patients had a median age of 57 years (range 27 to 70 years; with 5% above 65 years); 64% were male; 81% were white, 19% black or african american, and 21% hispanic; 37% had a bmi ≥ 30 kg/m2; the median baseline hcv rna level was 6.7 log10 iu/ml; 75% had no cirrhosis (metavir fibrosis score f0-3) and 25% had cirrhosis (metavir fibrosis score f4); 78% had hcv genotype 1a of which 45% carried q80k at baseline, and 22% had hcv genotype 1b; 86% had non-cc il28b alleles (ct or tt); 76% were prior null responders to peginterferon alfa and ribavirin, and 24% were treatment-naïve.